We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$387M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$332M
3
NOW icon
ServiceNow
NOW
+$265M
4
NYT icon
New York Times
NYT
+$189M
5
MXIM
Maxim Integrated Products
MXIM
+$152M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$456M
2
IPHI
INPHI CORPORATION
IPHI
+$311M
3
IQV icon
IQVIA
IQV
+$278M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$277M
5
EDU icon
New Oriental
EDU
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 29.51%
2 Technology 16.43%
3 Financials 13.12%
4 Communication Services 9.43%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMRX
301
DELISTED
Chimerix, Inc.
CMRX
– –
-1,300,000
Closed -$12.5M
JWSM.U
302
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
– –
-800,000
Closed -$8.12M
SLAMU
303
DELISTED
Slam Corp. Unit
SLAMU
– –
-70,508
Closed -$699K
CVIIU
304
DELISTED
Churchill Capital Corp VII Units
CVIIU
– –
-1,000,000
Closed -$9.97M
DMTK
305
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-200,000
Closed -$10.2M
DCPH
306
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-300,000
Closed -$13.5M
NGM
307
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-375,000
Closed -$10.9M
KNTE
308
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-250,000
Closed -$7.79M
LCAHU
309
DELISTED
Landcadia Holdings IV, Inc. Units
LCAHU
– –
-500,000
Closed -$4.95M
SLACU
310
DELISTED
Social Leverage Acquisition Corp I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
SLACU
– –
-750,000
Closed -$7.46M
DISAU
311
DELISTED
Disruptive Acquisition Corporation I Unit
DISAU
– –
-1,400,000
Closed -$13.8M
FRXB.U
312
DELISTED
Forest Road Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
FRXB.U
– –
-1,250,000
Closed -$12.4M
TBCPU
313
DELISTED
Thunder Bridge Capital Partners III Inc. Units
TBCPU
– –
-750,000
Closed -$7.42M
FSRXU
314
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
– –
-600,000
Closed -$5.98M
CCVI.U
315
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
– –
-400,000
Closed -$4.02M
APGB.U
316
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
– –
-750,000
Closed -$7.49M
AAC.U
317
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
– –
-1,000,000
Closed -$10M
NSTD.U
318
DELISTED
Northern Star Investment Corp. IV Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTD.U
– –
-100,000
Closed -$992K
NSTC.U
319
DELISTED
Northern Star Investment Corp. III Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTC.U
– –
-100,000
Closed -$995K
HARP
320
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-25,000
Closed -$5.23M
PMGMU
321
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
– –
-150,000
Closed -$1.49M
FMIVU
322
DELISTED
Forum Merger IV Corporation Unit
FMIVU
– –
-1,000,000
Closed -$9.9M
IPVIU
323
DELISTED
InterPrivate IV InfraTech Partners Inc. Units
IPVIU
– –
-600,000
Closed -$5.93M
SGFY
324
DELISTED
Signify Health, Inc.
SGFY
– –
-100,000
Closed -$2.93M
CRZNU
325
DELISTED
Corazon Capital V838 Monoceros Corp Unit
CRZNU
– –
-1,000,000
Closed -$9.95M
11 12
13
14 15

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2021 Portfolio in Review

As of Q2 2021, Thomas Steyer held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thomas Steyer deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Thomas Steyer's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Thomas Steyer's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Thomas Steyer fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Thomas Steyer opened 164 new positions and closed 100 in Q2 2021.
  • Thomas Steyer's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.